Trytosaveabit commented on a stock · Jan 10 06:05

Update

$Aclaris Therapeutics(ACRS.US)$ Aclaris Therapeutics Announces Top-line Results from 4-Week Phase 2b Trial of ATI-1777 for Mild to Severe Atopic Dermatitis
4 MINUTES AGO, 7:00 AM EST
VIA GLOBENEWSWIRE

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

3508 Views

Comment

Trytosaveabit

1799Followers

29Following

21KVisitors